By Staff
Friday, May 17, 2024 12:24 AM
BENTONVILLE, Ark.—
Walmart Inc. (NYSE: WMT) has announced first quarter financial results for the three months ending on April 30, 2024, showcasing strong growth in revenue and operating income. The results shared by the omnichannel, global retailer are for Q1 of its 2025 fiscal year, which runs for 12 months ending January 31, 2025. Specific highlights for the first quarter include consolidated revenue of $161.5 billion, up 6.0 percent, or 5.8 percent constant currency versus the same period last year; reported operating income up $0.6 billion (9.6 percent) and adjusted operating income up 13.7 percent, attributed to higher gross margins and growth in membership income; and growth in global e-commerce sales by 21 percent, led by store-fulfilled pickup/delivery and marketplace.
By Staff
Friday, May 17, 2024 12:21 AM
OBERKOCHEN, Germany—The
Zeiss Group (CZMWY) has reported the results of the first half of fiscal year 2023/24. The group generated revenue totaling €5.304 million for the period ended March 31, 2024, which is an increase of 10 percent compared with the comparable period the previous year. All four Zeiss segments contributed to the company's growth, Zeiss noted. Earnings before interest and taxes (EBIT) totaled €739 million, compared with €-178 million in the prior-year period. Expenditures on research and development remained at 15 percent of revenue, according to the company.
By Staff
Thursday, May 16, 2024 12:24 AM
TOKYO—
Hoya Corporation (7741:Tokyo) has announced consolidated revenue of 196.8 million yen for the fourth quarter ending March 31, 2024, up 6 percent from year-ago, and down 1 percent on a constant currency basis. Pretax profit rose to 72.1 million yen, a 34 percent increase versus year-ago, up 27 percent with the constant currency effect. Operating profit slipped 1 percent to 53 million yen compared to the prior-year period, a decrease of 5 percent in constant currency, according to Hoya.
By Staff
Thursday, May 16, 2024 12:21 AM
NEW YORK—
Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, has announced its financial and operating results for the quarter ended March 31, 2024.
By Staff
Wednesday, May 15, 2024 12:24 AM
GENEVA—
Alcon (SIX/NYSE:ALC), a global leader in eyecare, reported its financial results for the three months ended March 31, 2024. Sales were $2.4 billion, for the first quarter of 2024, an increase of 5 percent on a reported basis and 7 percent on a constant currency basis, compared with Q1 of 2023. "Our first-quarter results reflect the outstanding work done by our more than 25,000 associates across both our surgical and vision care franchises," said David J. Endicott, Alcon's chief executive officer.
By Staff
Wednesday, May 15, 2024 12:21 AM
NASHVILLE, Tenn.—
Harrow, a U.S. eyecare pharmaceutical company, (Nasdaq: HROW) has announced its results for the first quarter ended March 31, 2024. In the first quarter of 2024, Harrow recorded revenues of $34.6 million, a 33 percent increase over the $26.1 million realized in the prior-year quarter.
By Staff
Wednesday, May 15, 2024 12:15 AM
ATLANTA—
Alimera Sciences, Inc., a global pharmaceutical company specializing in retinal health, has announced financial results for the first quarter of 2024. The company reported net revenue of $23.0 million, up 70 percent compared with the prior-year quarter.
By Staff
Tuesday, May 14, 2024 12:21 AM
ORLANDO, Fla.—
Lensar, Inc. (Nasdaq: LNSR), a medical technology company focused on femtosecond laser treatment of cataracts, has announced financial results for the quarter ended March 31, 2024, and provided an update on key operational initiatives.
By Staff
Tuesday, May 14, 2024 12:18 AM
ROCHESTER, N.Y.—
Vuzix Corporation, a supplier of smart glasses and augmented reality (AR) technologies and products, has announced first-quarter results for 2024.
By Staff
Monday, May 13, 2024 12:21 AM
EMERYVILLE, Calif.—
NovaBay Pharmaceuticals, Inc., a developer of eyecare, skin care and wound care products, has reported its financial results for the three months ended March 31, 2024. Net product sales for the first quarter of 2024 were $2.6 million
By Staff
Monday, May 13, 2024 12:18 AM
VANCOUVER, British Columbia—
KITS Eyecare Ltd., a leading vertically integrated eyecare provider, has reported its results for the first quarter ended March 31, 2024. Revenue increased by 26 percent to $34.8 million.
By Staff
Monday, May 13, 2024 12:15 AM
ALPHARETTA, Ga.—
Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, has reported financial results for the first quarter ended March 31, 2024.
By Staff
Friday, May 10, 2024 12:27 AM
NEW YORK—
Warby Parker Inc. (NYSE: WRBY), has announced financial results for the first quarter ended March 31, 2024. Net revenue increased $28.0 million, or 16.3 percent, to $200.0 million, as compared with the prior-year period. The company also announced that average revenue per customer increased 9.6 percent year-over-year to $296 with increased active customer growth of 3.2 percent to 2.36 million.
By Staff
Friday, May 10, 2024 12:24 AM
LONGARONE and MILAN, Italy—The board of directors of
Marcolin approved the economic and financial results of the group as of March 31, 2024. In the first three months of 2024, Marcolin has continued to consolidate its performances, in line with the results registered in 2023, carrying out its growth path undertaken in recent years.
By Staff
Friday, May 10, 2024 12:15 AM
IRVINE, Calif.—
Tarsus Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutic eyecare treatments, has announced financial results for the first quarter ended March 31, 2024.